NASDAQ:FMED Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News $25.90 +0.15 (+0.56%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends About Fidelity Disruptive Medicine ETF (NASDAQ:FMED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FMED alerts:Sign Up Key Stats Today's Range$25.60▼$25.9250-Day Range$24.66▼$26.6152-Week Range$23.32▼$26.79Volume6,558 shsAverage Volume5,851 shsMarket Capitalization$54.32 millionAssets Under Management$55.35 millionDividend Yield0.43%Net Expense Ratio0.50%Aggregate RatingModerate Buy ETF OverviewThe Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Read More… Fidelity Disruptive Medicine ETF ExpensesTypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.55%0.51%0.52%Other Expenses0.00%0.57%0.50%0.46%0.53%Total Expense0.50%0.72%0.72%0.66%0.71%Fee Waiver0.00%-0.72%-0.50%-0.31%-0.56%Net Expense0.50%0.60%0.62%0.60%0.60% Receive FMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address FMED ETF News HeadlinesFidelity Disruptive Medicine ETF declares $0.112 dividendDecember 22, 2024 | seekingalpha.comSee More Headlines FMED ETF - Frequently Asked Questions How have FMED shares performed this year? Fidelity Disruptive Medicine ETF's stock was trading at $24.66 at the start of the year. Since then, FMED shares have increased by 4.9% and is now trading at $25.8650. View the best growth stocks for 2025 here. How do I buy shares of Fidelity Disruptive Medicine ETF? Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerFidelity Fund NameFidelity Disruptive Medicine ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FMED Inception Date6/12/2023 Fund ManagerNiamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings62 Fund Statistics Assets Under Management$55.35 million Average Daily Volume$0.00 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorFidelity Management & Research Company LLC AdvisorFidelity Management & Research Company LLC CustodianState Street Bank and Trust Company DistributorFidelity Distributors Company LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest9,100 shs Miscellaneous Outstanding Shares2,100,000Beta0.94 Creation Fee$200.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report Top 10 FMED HoldingsBoston Scientific (NYSE:BSX)Holding Weight: 7.10%Fidelity Securities Lending Cash Central FundHolding Weight: 5.05%Intuitive Surgical (NASDAQ:ISRG)Holding Weight: 4.74%Insulet (NASDAQ:PODD)Holding Weight: 4.57%UnitedHealth Group (NYSE:UNH)Holding Weight: 4.08%Danaher (NYSE:DHR)Holding Weight: 3.82%argenx (NASDAQ:ARGX)Holding Weight: 3.50%Penumbra (NYSE:PEN)Holding Weight: 3.03%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.01%Exact Sciences (NASDAQ:EXAS)Holding Weight: 2.96%Full Holdings DetailsFMED Sector ExposureFMED Industry Exposure This page (NASDAQ:FMED) was last updated on 2/12/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.The Trump administration's new tariffs have already begun to shake the economy. The impact is real, and the cl...Colonial Metals | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | Sponsored$589 billion wiped out overnightYou need to watch this before you invest another cent in AI. Because more than $589 billion was wiped out o...Porter & Company | SponsoredElon has entered the MarkBeat conversationSpivey's firm accurately warned of both the 2008 and 2020 stock market crashes and have charged institutional ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.